Harmony Biosciences Holdings Inc (HRMY) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Harmony Biosciences Holdings inc   (NASDAQ: HRMY)
 

Harmony Biosciences Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Harmony Biosciences Holdings Inc inventory turnover ratio, the Harmony Biosciences Holdings Inc 's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 45.11 in the third quarter 2026, HRMY's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Harmony Biosciences Holdings Inc in Sep 30 2026 quarter, has decreased to 8 days, compare to 9 days, in the Jun 30 2026 quarter.

Within Healthcare sector 2 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 110 in the second quarter 2026, to 124.

HRMY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Harmony Biosciences Holdings Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HRMY Inventory Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Inventory Growth -14.69 % 4.26 % -17.28 % -25.58 % -0.48 %
Y / Y Cost of Sales Growth 36.76 % 66.31 % 41.94 % 27.27 % 40.48 %
Inventory Turnover Ratio (TTM) 45.11 39.56 35.73 32.03 27.56
HRMY's Total Ranking # 124 # 110 # 91 # 67 #
Average inventory processing period 8 9 10 11 13
Seq. Inventory Growth -7.69 % 20.43 % -1.42 % -22.16 % 12.82 %
Seq. Cost of Sales Growth 27.67 % 43.63 % -37.14 % 18.64 % 55.26 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 0
Healthcare Sector # 3
Overall Market # 124

Inventory Turnover Ratio Statistics
High Average Low
39.56 20.94 4.25
(Jun 30 2026)   (Dec 31 2020)



HRMY Company Profile >> Back to HRMY Efficiency Comparisons >> Compare HRMY Inventory Turnover Ratio to its Competitors

Financial Statements
Harmony Biosciences Holdings Inc 's Inventories $ 6 Millions Visit HRMY's Balance sheet
Harmony Biosciences Holdings Inc 's Cost of Revenues TTM $ 258 Millions Visit HRMY's Income Statement
What are HRMY's Sales? Visit HRMY's Sales by Segment

Other Inventory Turnover Ratios
Harmony Biosciences Holdings Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HRMY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HRMY's Competitors
Inventory Turnover Ratio for HRMY's Suppliers
Inventory Turnover Ratio for HRMY's Customers

You may also want to know
HRMY's Sales Growth Rates HRMY's Pe Price to earnings ratio HRMY's Receivables Turnover Ratio HRMY's Stock Quote
HRMY's Net Income Growth Rates HRMY's Ps Price to Sales ratio HRMY's Sales per Employee HRMY's Asset Turnover Ratio
HRMY's Net Margin HRMY's Pb Price to Book ratio HRMY's Financial Strength Ratios HRMY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Sep 30 2026 Inventories at quarter ending Sep 30 2026
Healthcare Services Group Inc   98.49 $ 1,577.222  Millions$ 16  Millions
Quest Diagnostics Inc  36.62 $ 7,920.000  Millions$ 216  Millions
Teladoc Health Inc   23.99 $ 775.669  Millions$ 32  Millions
Adapthealth Corp   21.56 $ 2,649.368  Millions$ 123  Millions
Labcorp Holdings Inc   19.44 $ 10,367.400  Millions$ 533  Millions
Cryo cell International Inc   16.60 $ 6.680  Millions$ 0  Millions
Alnylam Pharmaceuticals Inc   12.28 $ 1,135.254  Millions$ 92  Millions
Brightspring Health Services Inc   11.57 $ 7,583.638  Millions$ 655  Millions
Tarsus Pharmaceuticals Inc   10.68 $ 49.325  Millions$ 5  Millions
Sotera Health Company  10.25 $ 558.509  Millions$ 54  Millions

Date modified: 2026-11-05T10:38:16+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.